197 related articles for article (PubMed ID: 19109149)
1. Ly49D engagement on T lymphocytes induces TCR-independent activation and CD8 effector functions that control tumor growth.
Merck E; Voyle RB; MacDonald HR
J Immunol; 2009 Jan; 182(1):183-92. PubMed ID: 19109149
[TBL] [Abstract][Full Text] [Related]
2. Ly49D-mediated ITAM signaling in immature thymocytes impairs development by bypassing the pre-TCR checkpoint.
Merck E; Lees RK; Voyle RB; Held W; MacDonald HR
J Immunol; 2011 Jul; 187(1):110-7. PubMed ID: 21632721
[TBL] [Abstract][Full Text] [Related]
3. Naive CD8+ T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells.
Wang B; Maile R; Greenwood R; Collins EJ; Frelinger JA
J Immunol; 2000 Feb; 164(3):1216-22. PubMed ID: 10640733
[TBL] [Abstract][Full Text] [Related]
4. Expansion and function of CD8+ T cells expressing Ly49 inhibitory receptors specific for MHC class I molecules.
Anfossi N; Robbins SH; Ugolini S; Georgel P; Hoebe K; Bouneaud C; Ronet C; Kaser A; DiCioccio CB; Tomasello E; Blumberg RS; Beutler B; Reiner SL; Alexopoulou L; Lantz O; Raulet DH; Brossay L; Vivier E
J Immunol; 2004 Sep; 173(6):3773-82. PubMed ID: 15356124
[TBL] [Abstract][Full Text] [Related]
5. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
Shier P; Ngo K; Fung-Leung WP
J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
[TBL] [Abstract][Full Text] [Related]
6. Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells.
Malek TR; Yu A; Scibelli P; Lichtenheld MG; Codias EK
J Immunol; 2001 Feb; 166(3):1675-83. PubMed ID: 11160210
[TBL] [Abstract][Full Text] [Related]
7. Class I- and class II-reactive TCRs coexpressed on CD4+ T cells both trigger CD4/CD8-shared and CD4-unique functions.
Asnagli H; Schmitt-Verhulst AM; Guimezanes A
J Immunol; 1997 May; 158(10):4533-42. PubMed ID: 9144464
[TBL] [Abstract][Full Text] [Related]
8. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
[TBL] [Abstract][Full Text] [Related]
9. Transgenic expression of Ly49A on T cells impairs a specific antitumor response.
Brawand P; Lemonnier FA; MacDonald HR; Cerottini JC; Held W
J Immunol; 2000 Aug; 165(4):1871-6. PubMed ID: 10925266
[TBL] [Abstract][Full Text] [Related]
10. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
[TBL] [Abstract][Full Text] [Related]
11. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
[TBL] [Abstract][Full Text] [Related]
12. A "chimeric" C57l-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor.
Mehta IK; Smith HR; Wang J; Margulies DH; Yokoyama WM
Cell Immunol; 2001 Apr; 209(1):29-41. PubMed ID: 11414734
[TBL] [Abstract][Full Text] [Related]
13. Notch2 signaling is required for potent antitumor immunity in vivo.
Sugimoto K; Maekawa Y; Kitamura A; Nishida J; Koyanagi A; Yagita H; Kojima H; Chiba S; Shimada M; Yasutomo K
J Immunol; 2010 May; 184(9):4673-8. PubMed ID: 20351182
[TBL] [Abstract][Full Text] [Related]
14. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
15. TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expression.
Yrlid U; Petersson E; Dohlsten M; Hedlund G
Cell Immunol; 1996 Nov; 173(2):287-94. PubMed ID: 8912889
[TBL] [Abstract][Full Text] [Related]
16. Divergent roles for CD4+ T cells in the priming and effector/memory phases of adoptive immunotherapy.
Hu HM; Winter H; Urba WJ; Fox BA
J Immunol; 2000 Oct; 165(8):4246-53. PubMed ID: 11035058
[TBL] [Abstract][Full Text] [Related]
17. Activating Receptors for Self-MHC Class I Enhance Effector Functions and Memory Differentiation of NK Cells during Mouse Cytomegalovirus Infection.
Nabekura T; Lanier LL
Immunity; 2016 Jul; 45(1):74-82. PubMed ID: 27438766
[TBL] [Abstract][Full Text] [Related]
18. Bcl10 plays a divergent role in NK cell-mediated cytotoxicity and cytokine generation.
Malarkannan S; Regunathan J; Chu H; Kutlesa S; Chen Y; Zeng H; Wen R; Wang D
J Immunol; 2007 Sep; 179(6):3752-62. PubMed ID: 17785812
[TBL] [Abstract][Full Text] [Related]
19. In vivo impact of CpG1826 oligodeoxynucleotide on CD8 T cell primary responses and survival.
Beloeil L; Tomkowiak M; Angelov G; Walzer T; Dubois P; Marvel J
J Immunol; 2003 Sep; 171(6):2995-3002. PubMed ID: 12960324
[TBL] [Abstract][Full Text] [Related]
20. A redundant role of the CD3 gamma-immunoreceptor tyrosine-based activation motif in mature T cell function.
Haks MC; Cordaro TA; van den Brakel JH; Haanen JB; de Vries EF; Borst J; Krimpenfort P; Kruisbeek AM
J Immunol; 2001 Feb; 166(4):2576-88. PubMed ID: 11160319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
